Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-13 | Ms. Jane Okun BombaIndependent Director | -2,85k | 6,96k | Sale to Issuer | 2,44 | 349,43k | -0,81% |
| 2026-05-13 | Dr. Wendell E. PritchettIndependent Director | -3,37k | 8,22k | Sale to Issuer | 2,44 | 98,44k | -3,31% |
| 2026-05-13 | Dr. Saurabh SahaIndependent Director | -8,18k | 19,95k | Sale to Issuer | 2,44 | 108,34k | -7,02% |
| 2026-05-13 | Mr. Kenneth L. CornickIndependent Director | -5,99k | 14,62k | Sale to Issuer | 2,44 | 1,14M | -0,52% |
| 2026-05-13 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -2,84k | 6,93k | Sale to Issuer | 2,44 | 446,94k | -0,63% |
| 2026-05-13 | Ms. Suzanne Elizabeth HeywoodIndependent Director | -19,69k | 48,04k | Sale to Issuer | 2,44 | 31,72k | -38,30% |
| 2026-05-01 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -19,89k | 55,50k | Sale to Issuer | 2,79 | 983,37k | -1,98% |
| 2026-03-31 | Mr. Kenneth L. CornickIndependent Director | -2,27k | 5,75k | Sale to Issuer | 2,53 | 1,12M | -0,20% |
| 2026-03-31 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -1,29k | 3,27k | Sale to Issuer | 2,53 | 410,31k | -0,31% |
| 2026-03-31 | Ms. Jane Okun BombaIndependent Director | -621,00 | 1,57k | Sale to Issuer | 2,53 | 290,01k | -0,21% |
| 2026-03-15 | Mr. William E. GraffExec. VP & Chief Information Officer | -23,84k | 61,26k | Sale to Issuer | 2,57 | 834,12k | -2,78% |
| 2026-03-15 | Mr. Matitiahu Shem TovCEO & Director | -125,47k | 322,46k | Sale to Issuer | 2,57 | 2,66M | -4,51% |
| 2026-03-15 | Mr. Michael EastonSenior VP of Finance & CAO | -30,46k | 78,27k | Sale to Issuer | 2,57 | 699,31k | -4,17% |
| 2026-03-13 | Mr. Michael EastonSenior VP of Finance & CAO | -26,50k | 0,00 | Other Disposition | - | 699,31k | -3,65% |
| 2026-03-15 | Mr. Jonathan M. CollinsExec. VP & CFO | -43,99k | 113,05k | Sale to Issuer | 2,57 | 1,15M | -3,70% |
| 2026-03-16 | Mr. Jonathan M. CollinsExec. VP & CFO | -35,74k | 0,00 | Other Disposition | - | 1,15M | -3,03% |
| 2026-03-15 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -35,40k | 90,98k | Sale to Issuer | 2,57 | 1,00M | -3,41% |
| 2026-03-01 | Mr. William E. GraffExec. VP & Chief Information Officer | -20,83k | 47,90k | Sale to Issuer | 2,30 | 603,25k | -3,34% |
| 2026-03-01 | Mr. Michael EastonSenior VP of Finance & CAO | -27,84k | 64,03k | Sale to Issuer | 2,30 | 474,19k | -5,55% |
| 2026-03-01 | Mr. Jonathan M. CollinsExec. VP & CFO | -41,64k | 95,77k | Sale to Issuer | 2,30 | 391,90k | -9,60% |
| 2026-03-01 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -37,34k | 85,89k | Sale to Issuer | 2,30 | 326,61k | -10,26% |
| 2026-02-18 | Mr. William E. GraffExec. VP & Chief Information Officer | -2,45k | 4,37k | Sale to Issuer | 1,78 | 619,81k | -0,39% |
| 2026-02-18 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -18,12k | 32,24k | Sale to Issuer | 1,78 | 278,95k | -6,10% |
| 2026-02-18 | Mr. Michael EastonSenior VP of Finance & CAO | -3,52k | 6,27k | Sale to Issuer | 1,78 | 497,76k | -0,70% |
| 2026-02-18 | Mr. Jonathan M. CollinsExec. VP & CFO | -17,40k | 30,96k | Sale to Issuer | 1,78 | 338,04k | -4,89% |
| 2025-12-08 | Impactive Capital LPSocietà | -15,32M | 40,82M | Vendita | 2,00 - 3,69 | 23,02M | -39,95% |
| 2025-12-31 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -479,00 | 1,60k | Sale to Issuer | 3,34 | 391,34k | -0,12% |
| 2025-12-31 | Mr. Kenneth L. CornickIndependent Director | -2,40k | 8,01k | Sale to Issuer | 3,34 | 1,11M | -0,22% |
| 2025-12-31 | Ms. Jane Okun BombaIndependent Director | -243,00 | 811,62 | Sale to Issuer | 3,34 | 279,27k | -0,09% |
| 2025-12-01 | Mr. Bar VeinsteinPresident of Academia & Government | -309,90k | 1,16M | Automatic Disposition | 3,74 | 177,11k | -63,63% |
| 2025-11-15 | Mr. Michael EastonSenior VP of Finance & CAO | -50,52k | 174,80k | Sale to Issuer | 3,46 | 494,17k | -9,27% |
| 2025-11-10 | Mr. Kenneth L. CornickIndependent Director | 100,00k | 345,00k | Acquisto | 3,45 | 1,10M | 9,97% |
| 2025-10-31 | Mr. Kenneth L. CornickIndependent Director | 725,00k | 2,48M | Acquisto | 3,38 - 3,52 | 1,00M | 261,02% |
| 2025-10-31 | Cambridge Information Group, Inc.Società | 1,46M | 4,86M | Acquisto | 3,33 | 25,60M | 6,05% |
| 2025-09-30 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -419,00 | 1,60k | Sale to Issuer | 3,83 | 376,48k | -0,11% |
| 2025-09-30 | Ms. Jane Okun BombaIndependent Director | -18,00 | 68,94 | Sale to Issuer | 3,83 | 270,91k | -0,01% |
| 2025-09-30 | Mr. Kenneth L. CornickIndependent Director | -1,52k | 5,84k | Sale to Issuer | 3,83 | 277,76k | -0,55% |
| 2025-08-13 | Mr. Jonathan M. CollinsExec. VP & CFO | -140,65k | 599,15k | Sale to Issuer | 4,26 | 319,86k | -30,54% |
| 2025-08-15 | Mr. Jonathan M. CollinsExec. VP & CFO | -48,39k | 0,00 | Other Disposition | - | 319,86k | -13,14% |
| 2025-08-13 | Mr. William E. GraffExec. VP & Chief Information Officer | -23,53k | 100,22k | Sale to Issuer | 4,26 | 615,15k | -3,68% |
| 2025-08-13 | Mr. Matitiahu Shem TovCEO & Director | -90,66k | 386,22k | Sale to Issuer | 4,26 | 1,65M | -5,20% |
| 2025-08-13 | Mr. Henry LevyPresident of Life Sciences & Healthcare | -70,75k | 301,38k | Sale to Issuer | 4,26 | 260,22k | -21,38% |
| 2025-08-13 | Mr. Gordon SamsonInsider | -22,58k | 96,20k | Sale to Issuer | 4,26 | 775,25k | -2,83% |
| 2025-08-01 | Mr. Kenneth L. CornickIndependent Director | 165,00k | 617,10k | Acquisto | 3,74 | 275,00k | 150,00% |
| 2025-06-30 | Ms. Jane Okun BombaIndependent Director | -306,00 | 1,32k | Sale to Issuer | 4,30 | 263,42k | -0,12% |
| 2025-06-30 | Mr. Andrew M. SnyderIndependent Non-Executive Chairman of the Board | -527,00 | 2,27k | Sale to Issuer | 4,30 | 363,52k | -0,14% |
| 2025-07-01 | Mr. Gordon SamsonInsider | -100,00k | 453,00k | Automatic Disposition | 4,53 | 744,07k | -11,85% |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
